biological diagnosis (A. flavus on cultures of deep operative wound samples obtained from normally sterile tissues, such as cartilage or bone, during у1 episode), and (3) receipt of cardiac operation in the affected unit. Nine of 149 patients who underwent operations during the epidemic fulfilled these criteria. A patient was considered to have had a relapse if the patient had у1 episode of proven Aspergillus infection and developed new signs of infection around the sternum 11 month after apparent healing.
The A. Z. Sint-Jan General Hospital (Brugge, Belgium) is a 774-bed secondary care hospital that was built in 1966. From mid-January to mid-April 1998, there was an epidemic of sternal wound infections that occurred among patients who had undergone CABG surgery [3] . During this epidemic, the presence of A. flavus was demonstrated in the air of the cardiac surgery operating room, with a conidia level of 150 cfu per 1000 L of air on quantitative culture. Cultures of samples from the high-efficiency particulate air filtering systems were sterile, but massive growth of A. flavus was noted on cultures of samples from electronic equipment in the operating room and from the environment (air and surfaces) of semicritical areas adjacent to the cardiac surgery ward. No patients other than those in the cardiac surgery unit had invasive A. flavus infection. Although the source of the A. flavus contamination was never detected, rigid infection-control procedures, including the dismantling of all equipment and thorough decontamination and cleaning of the equipment and ceiling, ended the epidemic, as described elsewhere [3] . Genome typing of the A. flavus strains recovered from the environment and from some of the infected patients indicated that the strains were highly related [9] .
The demographic, surgical, and clinical characteristics of the patients are summarized in table 1. All patients had у1 of the following factors, which are known to predispose for sternal wound infection: obesity, diabetes, chronic obstructive pulmonary disease, and the surgical use of у1 internal mammary artery. Two patients received high-dose treatment with corticosteroids (methylprednisolone, 32 mg/day for у1 week) before undergoing the operation [1, 2] .
The median interval between surgery and the onset of signs of infection was 14 days (range, 5-147 days), and 4 patients (patients 1, 2, 6, and 9) presented with sternal wound infection presented with refractory pleural effusion, but the patient's condition subsequently evolved to septic shock and multiorgan failure, and the patient died. In patients 1-7, systemic symptoms remained moderate during the whole course of infection. Local symptoms consisted of wound dehiscence, local inflammatory signs, pleural effusion, and the formation of sternocutaneous fistulas and substernal collections. The median Creactive protein level before surgical treatment was 5.8 mg/dL (range, 1.2-45.1 mg/dL), the median WBC count before surgical treatment was 8900 cells/mm 3 (range, 5900-25,000 cells/ mm 3 ), and the median erythrocyte sedimentation rate before surgical treatment was 43 mm/h (range, 8-91 mm/h).
The following MICs were determined for the A. flavus strain: amphotericin B, 4 mg/mL; fluconazole, 164 mg/mL; and itraconazole, 0.03-0.06 mg/mL (susceptibility testing kindly done by Dr. F. Odds; University of Aberdeen, Scotland, United Kingdom). This indicates that the strain was susceptible to itraconazole but resistant to both fluconazole and amphotericin B. It is well known that A. flavus frequently has reduced susceptibility to amphotericin B but good susceptibility to itraconazole [10] .
The treatment regimens are summarized in table 2. Seven patients were treated with a combination of surgical debridement and administration of itraconazole oral solution (b-hydroxy-cyclodextrin [b-OHCD]; Sporanox oral solution; Janssens Pharma). Itraconazole was given at a dosage of 200 mg twice per day for 2 months, if possible. Among the patients treated with this regimen, there was 1 death (patient 9). There were also 3 patients (patients 1, 3, and 4) who had relapses several months after the initial episode and who required 1 or 2 additional courses of therapy. One patient (patient 5) was treated with surgery alone. The patient who presented with fulminate mediastinitis (patient 8) was treated with surgery and administration of amphotericin B.
Itraconazole oral solution was well tolerated by 5 of the 6 evaluated patients (patient 9 was to ill for tolerance to be evaluated). Only 1 patient needed a dose reduction because of nausea or diarrhea. Another patient (patient 4) had asymptomatic elevation of alanine aminotransferase and aspartate aminotransferase levels (up to 5-fold of the upper limit of normal). Serum trough levels of itraconazole, which were measured by use of high-performance liquid chromatography at the Janssen Research Foundation (Beerse, Belgium), were in the therapeutic range (i.e., 791-8066 ng/mL).
Surgical treatment consisted of marsupialization of abscesses, removal of the sternal wires, curettage of all affected tissue, and open-or closed-wound treatment. The 3 patients who had relapses required multiple surgical interventions. Discussion. We have described the clinical features and treatment of 9 patients affected during an epidemic of sternal wound infections due to A. flavus after they underwent cardiac surgery. Classic post-cardiac surgery sternal wound infections are mostly caused by staphylococci and Enterobacteriaceae.
Signs of infection usually appear early after the operation. The onset and clinical course of infection are rapid, and sepsis is a major presenting symptom. In contrast, the A. flavus sternal wound infections reported here developed a median of 14 days after surgery, and the onset of infection was insidious in 8 of the 9 cases, with only moderate systemic involvement. However, local infection tended to be destructive and refractory to therapy, and relapse was quite common (3 of 9 patients had relapses). In 2 patients, the infection evolved to septic shock and multiorgan failure, and the patients died.
Treatment of sternal wound infection due to A. flavus-as is the case for all sternal wound infections that occur after CABG surgery-is based on a combined surgical and medical approach [5, 7, 11] . Although amphotericin B remains the standard treatment for invasive aspergillosis, the new galenic formulation of itraconazole as oral solution that has a better bioavailability is a valuable alternative. The itraconazole oral solution (b-OHCD) was chosen in view of the susceptibility results for A. flavus and the need for prolonged outpatient treatment. Of the 9 patients we describe, 2 patients died and 3 patients had multiple relapses that required multiple courses of treatment.
Although rare, Aspergillus infection must be considered in the differential diagnosis of slowly progressive but destructive wound infections, culture-negative pleural effusion, and culture-negative mediastinitis that occurs after cardiac surgery. Treatment requires a combined surgical and antifungal approach.
